These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 1673792)

  • 1. Loss of heterozygosity on the short arm of chromosome 17 is associated with high proliferative capacity and DNA aneuploidy in primary human breast cancer.
    Chen LC; Neubauer A; Kurisu W; Waldman FM; Ljung BM; Goodson W; Goldman ES; Moore D; Balazs M; Liu E
    Proc Natl Acad Sci U S A; 1991 May; 88(9):3847-51. PubMed ID: 1673792
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evidence for a gene on 17p13.3, distal to TP53, as a target for allele loss in breast tumors without p53 mutations.
    Cornelis RS; van Vliet M; Vos CB; Cleton-Jansen AM; van de Vijver MJ; Peterse JL; Khan PM; Børresen AL; Cornelisse CJ; Devilee P
    Cancer Res; 1994 Aug; 54(15):4200-6. PubMed ID: 8033152
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prognostic significance of the loss of heterozygosity of Nm23-H1 and p53 genes in human colorectal carcinomas.
    Campo E; Miquel R; Jares P; Bosch F; Juan M; Leone A; Vives J; Cardesa A; Yague J
    Cancer; 1994 Jun; 73(12):2913-21. PubMed ID: 8199988
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Loss of heterozygosity on chromosome 10, 13q(Rb), 17p, and p53 gene mutations in human brain gliomas.
    Lee SH; Kim JH; Rhee CH; Kang YS; Lee JH; Hong SI; Choi KS
    J Korean Med Sci; 1995 Dec; 10(6):442-8. PubMed ID: 8924230
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Deletion of chromosome 17p loci in breast cancer cells detected by fluorescence in situ hybridization.
    Matsumura K; Kallioniemi A; Kallioniemi O; Chen L; Smith HS; Pinkel D; Gray J; Waldman FM
    Cancer Res; 1992 Jun; 52(12):3474-7. PubMed ID: 1350754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence for a second tumor suppressor gene on 17p linked to high S-phase index in primary human breast carcinomas.
    Merlo GR; Venesio T; Bernardi A; Cropp CS; Diella F; Cappa AP; Callahan R; Liscia DS
    Cancer Genet Cytogenet; 1994 Sep; 76(2):106-11. PubMed ID: 7923057
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of heterozygosity on chromosomes 17 and 18 in breast carcinoma: two additional regions identified.
    Cropp CS; Lidereau R; Campbell G; Champene MH; Callahan R
    Proc Natl Acad Sci U S A; 1990 Oct; 87(19):7737-41. PubMed ID: 1977164
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human breast cancer: frequent p53 allele loss and protein overexpression.
    Singh S; Simon M; Meybohm I; Jantke I; Jonat W; Maass H; Goedde HW
    Hum Genet; 1993 Feb; 90(6):635-40. PubMed ID: 8444469
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copy number neutral loss of heterozygosity at 17p and homozygous mutations of TP53 are associated with complex chromosomal aberrations in patients newly diagnosed with myelodysplastic syndromes.
    Svobodova K; Zemanova Z; Lhotska H; Novakova M; Podskalska L; Belickova M; Brezinova J; Sarova I; Izakova S; Lizcova L; Berkova A; Siskova M; Jonasova A; Cermak J; Michalova K
    Leuk Res; 2016 Mar; 42():7-12. PubMed ID: 26851439
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Role and mutational heterogeneity of the p53 gene in hepatocellular carcinoma.
    Nishida N; Fukuda Y; Kokuryu H; Toguchida J; Yandell DW; Ikenega M; Imura H; Ishizaki K
    Cancer Res; 1993 Jan; 53(2):368-72. PubMed ID: 8093350
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma.
    von Deimling A; Eibl RH; Ohgaki H; Louis DN; von Ammon K; Petersen I; Kleihues P; Chung RY; Wiestler OD; Seizinger BR
    Cancer Res; 1992 May; 52(10):2987-90. PubMed ID: 1349850
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Allelotype of breast cancer: cumulative allele losses promote tumor progression in primary breast cancer.
    Sato T; Tanigami A; Yamakawa K; Akiyama F; Kasumi F; Sakamoto G; Nakamura Y
    Cancer Res; 1990 Nov; 50(22):7184-9. PubMed ID: 1977515
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Loss of heterozygosity at 17p13.3-ter, distal to TP53, correlates with negative hormonal phenotype in sporadic breast cancer.
    Roncuzzi L; Brognara I; Baiocchi D; Amadori D; Gasperi-Campani A
    Oncol Rep; 2005 Aug; 14(2):471-4. PubMed ID: 16012732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Loss of heterozygosity on the short arm of chromosome 17 in uterine cervical carcinomas.
    Park SY; Kang YS; Kim BG; Lee SH; Lee ED; Lee KH; Park KB; Lee JH
    Cancer Genet Cytogenet; 1995 Jan; 79(1):74-8. PubMed ID: 7850756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Allelic loss on chromosome 17p and p53 mutations in human endometrial carcinoma of the uterus.
    Okamoto A; Sameshima Y; Yamada Y; Teshima S; Terashima Y; Terada M; Yokota J
    Cancer Res; 1991 Oct; 51(20):5632-5. PubMed ID: 1913680
    [TBL] [Abstract][Full Text] [Related]  

  • 16. p53 allele losses, mutations and expression in breast cancer and their relationship to clinico-pathological parameters.
    Thompson AM; Anderson TJ; Condie A; Prosser J; Chetty U; Carter DC; Evans HJ; Steel CM
    Int J Cancer; 1992 Feb; 50(4):528-32. PubMed ID: 1537617
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of heterozygosity on chromosome 17p13 in breast carcinomas identifies tumors with high proliferation index.
    Merlo GR; Venesio T; Bernardi A; Canale L; Gaglia P; Lauro D; Cappa AP; Callahan R; Liscia DS
    Am J Pathol; 1992 Jan; 140(1):215-23. PubMed ID: 1731526
    [TBL] [Abstract][Full Text] [Related]  

  • 18. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency.
    Frankel RH; Bayona W; Koslow M; Newcomb EW
    Cancer Res; 1992 Mar; 52(6):1427-33. PubMed ID: 1347252
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Chromosome arm 17p13.3: could HIC1 be the one ?].
    Chopin V; Leprince D
    Med Sci (Paris); 2006 Jan; 22(1):54-61. PubMed ID: 16386221
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Loss of heterozygosity on 17p in human breast carcinomas: defining the smallest common region of deletion.
    Devilee P; Cornelisse CJ; Kuipers-Dijkshoorn N; Jonker C; Pearson PL
    Cytogenet Cell Genet; 1990; 53(1):52-4. PubMed ID: 1969789
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.